Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Markus Leweke

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Current Topics in Behavioral Neurosciences|November 25, 2010
SchizophreniaF Markus Leweke
Current Pharmaceutical Design|June 22, 2012
Anandamide dysfunction in prodromal and established psychosisF Markus Leweke
Addiction Biology|May 17, 2008
Cannabis and psychiatric disorders: it is not only addictionF Markus Leweke, Dagmar Koethe
The International Journal of Neuropsychopharmacology|August 4, 2010
Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapineF Markus Leweke, Miriam Schneider
Medizinische Monatsschrift Fur Pharmazeuten|June 30, 2018
[In process]F Markus Leweke, Walter E Müller
Medizinische Monatsschrift Fur Pharmazeuten|June 30, 2018
Bipolar disorder: clinical overviewJuliane K Müller, F Markus Leweke
Medizinische Monatsschrift Fur Pharmazeuten|June 30, 2018
[In process]Juliane K Müller, F Markus Leweke
The New England Journal of Medicine|April 28, 2006
Clozapine alone versus clozapine and risperidone for refractory schizophreniaGuido Grass, Martin Hellmich, F Markus Leweke
Psychopharmacology|June 17, 2009
The endocannabinoid system as a target for modelling psychosisDagmar Koethe, Carolin Hoyer, F Markus Leweke
Pharmacopsychiatry|February 13, 2026
Correction: Cannabidiol and its Potential Evidence-Based Psychiatric Benefits - A Critical ReviewInga Dammann, Cathrin Rohleder, F Markus Leweke
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Current Topics in Behavioral Neurosciences|November 25, 2010
SchizophreniaF Markus Leweke
Current Pharmaceutical Design|June 22, 2012
Anandamide dysfunction in prodromal and established psychosisF Markus Leweke
Addiction Biology|May 17, 2008
Cannabis and psychiatric disorders: it is not only addictionF Markus Leweke, Dagmar Koethe
The International Journal of Neuropsychopharmacology|August 4, 2010
Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapineF Markus Leweke, Miriam Schneider
Medizinische Monatsschrift Fur Pharmazeuten|June 30, 2018
[In process]F Markus Leweke, Walter E Müller
Medizinische Monatsschrift Fur Pharmazeuten|June 30, 2018
Bipolar disorder: clinical overviewJuliane K Müller, F Markus Leweke
Medizinische Monatsschrift Fur Pharmazeuten|June 30, 2018
[In process]Juliane K Müller, F Markus Leweke
The New England Journal of Medicine|April 28, 2006
Clozapine alone versus clozapine and risperidone for refractory schizophreniaGuido Grass, Martin Hellmich, F Markus Leweke
Psychopharmacology|June 17, 2009
The endocannabinoid system as a target for modelling psychosisDagmar Koethe, Carolin Hoyer, F Markus Leweke
Pharmacopsychiatry|February 13, 2026
Correction: Cannabidiol and its Potential Evidence-Based Psychiatric Benefits - A Critical ReviewInga Dammann, Cathrin Rohleder, F Markus Leweke
Pageof 12